Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
- Conditions
- Kidney Stones
- Interventions
- Device: LithoSpace Extracorporeal Shockwave Lithotripter
- Registration Number
- NCT00959153
- Lead Sponsor
- Advance Shockwave Technology GmbH
- Brief Summary
A total of 20 subjects presenting with urinary stone(s) in the kidney or ureter will be treated with an extracorporeal shockwave lithotripsy device to fragment the stones. Subjects will be followed for 14 days. If at the 14 day follow-up visit the subject continues to present with a stone size 4 mm or greater will have an option of retreatment or other intervention. If the subject consents to be retreated at this time, this subject will be followed up for another 14 days.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Diagnosis of a solitary Urinary stones in the renal pelvis or renal calyces or ureter
- Presence of one stone greater than 4 mm and less than 12 mm
- Urinary tract obstruction, acute or unresolved cholecystitis, cholangitis, pancreatitis or obstruction of the biliary duct system
- Impaction of stone to be treated
- Staghorn stones
- Failed or inadequate lithotripsy procedure within 3 months prior to study
- Coagulation abnormalities or anticoagulation therapy
- Pregnant or females of child-bearing potential General, spinal or epidural anesthesia is contraindicated
- Can not be positioned correctly for fluoroscopic imaging
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Kidney stones LithoSpace Extracorporeal Shockwave Lithotripter Kidney stones
- Primary Outcome Measures
Name Time Method stone fragmentation 14 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Allied Urological Services, LLC
🇺🇸New York, New York, United States
Metropolitan Lithotriptor Associates
🇺🇸Garden City, New York, United States